复发性低级别异型增生增加IBD患者高级别异型增生和结直肠癌风险
这项全国性队列研究利用荷兰国家病理登记库数据,纳入1991至2010年间4284例结肠低级别异型增生(LGD)的炎症性肠病(IBD)患者,中位随访6.4年。
要点
- 复发性LGD是IBD患者进展为高级别异型增生和结直肠癌的危险因素。
- 初始LGD后至少3年无肿瘤期与后续高级别异型增生和结直肠癌风险降低相关。
- 随访结肠镜中识别复发性LGD有助于风险分层。
核心结论
- 初始LGD后随访结肠镜发现复发性LGD是进展为高级别异型增生和结直肠癌的危险因素。
- 初始LGD后至少3年无肿瘤期与后续高级别异型增生和结直肠癌风险降低相关。
研究设计与样本
- 全国性队列研究,使用荷兰国家病理登记库数据,纳入1991至2010年间具有LGD且至少1次随访结肠镜的IBD患者,随访数据收集至2016年1月。
- 共识别4284例结肠LGD的IBD患者,中位随访6.4年。
主要发现
- 初始LGD后至少3年无肿瘤期对高级别异型增生和结直肠癌具有保护作用。
关键数值与推荐
- 无肿瘤期阈值:至少3年。
临床怎么用
- 对IBD合并LGD患者,随访结肠镜应关注复发性LGD以评估进展风险。
- 初始LGD后至少3年无肿瘤期可提示后续高级别异型增生和结直肠癌风险降低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The impact of recurrent low-grade dysplasia (LGD) on the risk of advanced neoplasia (high-grade dysplasia and colorectal cancer) in inflammatory bowel disease (IBD) patients is unknown. In addition, it is unclear how a neoplasia-free period after index LGD impacts this risk. We aimed to determine whether recurrent LGD is a risk factor for advanced neoplasia development and to evaluate the impact of a neoplasia-free time period after initial LGD diagnosis on the advanced neoplasia risk. METHODS: This is a nationwide cohort study using data from the Dutch National Pathology Registry to identify all IBD patients with LGD and ≥1 follow-up colonoscopy between 1991 and 2010 in the Netherlands. Follow-up data were collected until January 2016. We compared the cumulative advanced neoplasia incidence between patients with and without recurrent LGD at first follow-up colonoscopy using log-rank analysis. We subsequently studied the impact of a neoplasia-free period after initial LGD on the advanced neoplasia incidence. RESULTS: We identified 4284 IBD patients with colonic LGD with a median follow-up of 6.4 years. Recurrent LGD was a risk factor for advanced neoplasia (hazard ratio, 1.66; 95% confidence interval, 1.22-2.25; P = .001). A neoplasia-free period of at least 3 years after LGD protected against advanced neoplasia. CONCLUSIONS: Recurrent LGD at follow-up colonoscopy after initial LGD was a risk factor for advanced neoplasia. A neoplasia-free period of at least 3 years after initial LGD was associated with a reduced subsequent risk of advanced neoplasia.
引用
- de Jong ME, Kanne H, Nissen LHC, et al. Increased risk of high-grade dysplasia and colorectal cancer in inflammatory bowel disease patients with recurrent low-grade dysplasia. Gastrointest Endosc. 2020. PMID: 31923409. doi:10.1016/j.gie.2019.12.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。